Tobacco Settlement: Where's the Money?

Graphic: Leza Berardone Everybody wants a piece of the pie, especially when that pie is worth $206 billion. That is the total amount the states won from the tobacco companies last November in the largest civil settlement in U.S. history. Florida, Minnesota, Mississippi, and Texas had settled individually for a combined amount of $40 billion earlier. The payments will be made over the next 25 years, and even though the money is still not available to the states, a scramble over how to spend it is

Written byNadia Halim
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Graphic: Leza Berardone
Everybody wants a piece of the pie, especially when that pie is worth $206 billion. That is the total amount the states won from the tobacco companies last November in the largest civil settlement in U.S. history. Florida, Minnesota, Mississippi, and Texas had settled individually for a combined amount of $40 billion earlier. The payments will be made over the next 25 years, and even though the money is still not available to the states, a scramble over how to spend it is in progress.

Initially, many legislators were concerned that the federal government might attempt to recoup some of the states' tobacco settlement by claiming the payments from the tobacco companies were essentially third-party Medicaid reimbursements. However, in late May of this year President Bill Clinton signed a bill with an amendment that denies the federal government access to any of the money. With the recoupment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems